Phaarmasia

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE486I01016
  • NSEID:
  • BSEID: 523620
INR
100.47
7.77 (8.38%)
BSENSE

Nov 20

BSE+NSE Vol: 3.34 k

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Comparison
Company
Score
Quality
Valuation
Financial
Technical
Vineet Laborator
Samrat Pharma
Ajooni Biotech
ANG Lifesciences
Mangalam Drugs
Phaarmasia
Biofil Chemicals
Shelter Pharma
Chandra Bhagat
Onyx Biotec
Zenith Drugs
Why is Phaarmasia Ltd ?
1
With a Operating Losses, the company has a Weak Long Term Fundamental Strength
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of -1.09
  • The company has reported losses. Due to this company has reported negative ROCE
2
Negative results in Sep 26
  • PAT(Latest six months) At Rs 0.26 cr has Grown at -37.83%
  • NET SALES(Q) Lowest at Rs 6.28 cr
3
Risky - Negative EBITDA
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 114.91%, its profits have fallen by -48%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you sell?
  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Phaarmasia for you?

High Risk, High Return

Absolute
Risk Adjusted
Volatility
Phaarmasia
114.91%
1.36
84.36%
Sensex
-2.0%
-0.13
14.98%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
14.64%
EBIT Growth (5y)
10.49%
EBIT to Interest (avg)
-1.09
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-0.52
Sales to Capital Employed (avg)
2.38
Tax Ratio
18.79%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0.06%
ROCE (avg)
-9.91%
ROE (avg)
1.72%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
230
Industry P/E
40
Price to Book Value
3.10
EV to EBIT
-57.75
EV to EBITDA
-57.75
EV to Capital Employed
5.34
EV to Sales
1.51
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-4.34%
ROE (Latest)
1.35%
Loading Valuation Snapshot...
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
Mildly Bearish
RSI
No Signal
Bearish
Bollinger Bands
Bullish
Bullish
Moving Averages
Mildly Bearish (Daily)
KST
Mildly Bullish
Bullish
Dow Theory
Mildly Bullish
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

1What is working for the Company
CASH AND CASH EQUIVALENTS(HY)

Highest at Rs 11.73 cr

-12What is not working for the Company
PAT(Latest six months)

At Rs 0.26 cr has Grown at -37.83%

NET SALES(Q)

Lowest at Rs 6.28 cr

Loading Valuation Snapshot...
Here's what is working for Phaarmasia
Cash and Cash Equivalents - Half Yearly
Highest at Rs 11.73 cr
in the last six half yearly periods
MOJO Watch
Short Term liquidity is improving

Cash and Cash Equivalents

Here's what is not working for Phaarmasia
Net Sales - Quarterly
At Rs 6.28 cr has Fallen at -48.3% (vs previous 4Q average)
over average Net Sales of the previous four quarters of Rs 12.15 Cr
MOJO Watch
Near term sales trend is very negative

Net Sales (Rs Cr)

Profit After Tax (PAT) - Latest six months
At Rs 0.26 cr has Grown at -37.83%
Year on Year (YoY)
MOJO Watch
Near term PAT trend is negative

PAT (Rs Cr)

Net Sales - Quarterly
Lowest at Rs 6.28 cr
in the last five quarters
MOJO Watch
Near term sales trend is negative

Net Sales (Rs Cr)